FDA-Cleared, Next Generation Coagulation Monitor Offers Both Built-in
Controls, and Optional External Liquid Quality Controls
INDIANAPOLIS, Oct. 29 /PRNewswire/ -- Roche Diagnostics' newly launched CoaguChek XS Plus System offers built-in controls and optional, external liquid controls to help non-waived clinics monitoring anticoagulation ensure accurate PT/INR (clotting time) test results for patients taking blood thinner medication.
The handheld, battery-powered CoaguChek XS Plus System has the ability to store up to 500 patient and or liquid quality control results that can be searched by patient, date and time. The meter also is designed for data management connectivity with patient ID, operator lockout and quality control lockouts.
The CoaguChek XS Plus System is pending CLIA waiver approval by the Food and Drug Administration.
"Coupled with a systematic anticoagulation management approach, the CoaguChek XS Plus System can help physicians and laboratorians provide their patients with the current best practices in warfarin management," said Randy Pritchard, Director of Strategic Marketing for Point of Care Diagnostics at Roche Diagnostics. "That can help them increase their patients' time in therapeutic range, minimize adverse events, and address the new coagulation monitoring requirements in the Joint Commission's 2008 Patient Safety Goals."
Similar to the CoaguChek XS System using the CoaguChek XS PT Test
Strip, the CoaguChek XS Plus System performs two levels of onboard quality
controls as part of every PT/INR test, all in a single test chamber, a
feature designed to save time and provide enhanced confidence in the
quality of results. The CoaguChek PT test strip also neutralizes
therapeutic levels of heparin and low-molecular-weight heparin, enabling
physicians to do point-of-care testing on a broad range of anticoagulated
patients. The latest CoaguChek system, with the use of the CoaguChek PT
test strip, conti
|SOURCE Roche Diagnostics|
Copyright©2007 PR Newswire.
All rights reserved